Persistent luminescence of Eu, Mn, Dy doped calcium phosphates for in-vivo optical imaging
Creators
- 1. UPMC Univ Paris 06, CNRS, UMR 7574, Chimie de la Matière Condensée de Paris, Collège de France, 11 place Marcelin Berthelot, 75231 Paris Cedex 05 (France)
- 2. PSL Research University, Chimie ParisTech-CNRS, Institut de Recherche de Chimie Paris, 11 rue Pierre et Marie Curie, 75005 Paris (France)
- 3. Faculté des Sciences Pharmaceutiques et Biologiques, Université Paris Descartes, Sorbonne Paris Cité, Paris Cedex F-75270 (France)
- 4. Inserm U1022, Paris Cedex F-75270 (France)
- 5. Unité de Technologies Chimiques et Biologiques pour la Santé, CNRS, UMR 8258, Paris Cedex F-75270 (France)
Description
Biocompatible nanoparticles possessing persistent luminescence properties offer attractive possibilities for in vivo imaging applications as it allows an excitation of the sensors outside the animal before injection and a long-lasting emission of light. Here we report the development of highly biocompatible calcium phosphate nanoparticles doped with europium, Mn2+ and Ln3+ (Ln3+=Dy3+, Pr3+) ions synthesized by hydrothermal route and tailored to present red-near infrared persistent luminescence after UV excitation. Nanosize biphasic HAp/β-TCP compounds with sphere and rod-shaped were obtained. Two emission bands in the red-near infrared range were observed and attributed to 4T1→6A1 transitions of Mn2+ ions in HAp/β-TCP. An annealing treatment in reductive atmosphere post-synthesis was essential to reveal persistent luminescence properties. Indeed, such thermal treatment allows reducing Eu3+ ions in Eu2+ ions and generating required defaults as oxygen vacancies in the crystal necessary for red emission in accordance with persistent luminescence mechanism. These nanoparticles have been tested for the first time for in vivo imaging on small animal as proof of concept of prospective highly biocompatible nanoprobes. - Highlights: • Biocompatible HAp/b-TCP nanoparticles with persistent luminescence are investigated. • Reducing step induced persistent luminescence. • Nanoparticles have been tested for the first time for in vivo imaging. • Persistent luminescence is observed after 10 min in vivo.
Availability note (English)
Available from http://dx.doi.org/10.1016/j.jlumin.2015.07.024Additional details
Identifiers
- DOI
- 10.1016/j.jlumin.2015.07.024;
- PII
- S0022-2313(15)00405-6;
Publishing Information
- Journal Title
- Journal of Luminescence
- Journal Volume
- 170
- Journal Issue
- Part 2
- Journal Page Range
- p. 460-466
- ISSN
- 0022-2313
- CODEN
- JLUMA8
INIS
- Country of Publication
- Netherlands
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 49022555
- Subject category
- S36: MATERIALS SCIENCE;
- Descriptors DEI
- BIOMEDICAL RADIOGRAPHY; CALCIUM PHOSPHATES; DOPED MATERIALS; DYSPROSIUM IONS; EUROPIUM IONS; IN VIVO; LUMINESCENCE; MANGANESE IONS; NANOPARTICLES; PRASEODYMIUM IONS; SYNTHESIS
- Descriptors DEC
- ALKALINE EARTH METAL COMPOUNDS; CALCIUM COMPOUNDS; CHARGED PARTICLES; DIAGNOSTIC TECHNIQUES; EMISSION; IONS; MATERIALS; MEDICINE; NUCLEAR MEDICINE; OXYGEN COMPOUNDS; PARTICLES; PHOSPHATES; PHOSPHORUS COMPOUNDS; PHOTON EMISSION; RADIOLOGY
Optional Information
- Copyright
- Copyright (c) 2015 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.